China has completed a remote single-arm robotic surgery for a patient in the country Xizang Autonomous Region marking a major breakthrough in combini ...

Sophie Cromer, an 8-year-old from Alabama, has faced a challenging journey after being diagnosed with aplastic anemia at the ...

Bertrand Y. Tuan, MD, hematologist/oncologist at Pacific Hematology Oncology Associates and California Pacific Medical Center ...

Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a ...

Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial milestone payments ...

Study finds annual healthcare costs per patient are significantly higher than previously described– HHT costs are higher than other ...

The outlay, plus up to $1.1 billion in milestones, has secured Takeda ex-China rights to a molecule that could compete with ...

Takeda ( TSE:4502/NYSE:TAK ) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. (Nasdaq: KROS) to further develop, manufacture and commercialize ...

Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring relief to your symptoms and reduce your risk of experiencing more serious ...

Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

BMI's Relation to Cancer Therapy Mortality Risks Not So Straightforward Sep. 12, 2024 — Researchers examined the impact of obesity in relation to treatment and mortality from data on over ...

Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) — a rare, life-threatening disorder in which bone marrow ...